Quarterly report [Sections 13 or 15(d)]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
SCHEDULE OF OTHER CURRENT ASSETS

Other current assets consisted of the following as of March 31, 2026 and December 31, 2025:

  

    March 31, 2026     December 31, 2025  
Lab supplies   $ 961     $ 1,114  
Prepaid expenses     430       632  
Total other current assets   $ 1,391     $ 1,746  
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

 

         
    Three Months Ended  
    March 31,  
    2026     2025  
Basic weighted average number of common shares     22,786       4,420  
Potential dilutive effect of stock-based awards     9       17  
Dilutive effect of preferred stock     4,912       23,267  
Diluted weighted average number of common shares     27,707       27,704  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

         
    Three Months Ended  
    March 31,  
    2026     2025  
Options     246       277  
Restricted stock units (RSUs)     125       158  
Anti-dilutive securities     371       435